logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Pcm Trials Acquires Netherlands-Based Clinical Trial Service B.V., Becoming The Most Experienced Independent Provider Of Mobile Visit Services With The Largest Geographic Coverage Area In Support Of Decentralized Clinical Trials

Jan 10, 2024almost 2 years ago

Acquiring Company

PCM Trials

Acquired Company

Clinical Trial Service B.V

DenverLosserMarket ResearchPharmaceutical Manufacturing

Description

PCM Trials, a Denver, USA-based leader in providing mobile research nurses for decentralized clinical trials (DCTs), today announced the acquisition of Clinical Trial Service (CTS). The Losser, Netherlands-based private clinical research company has been a long-standing partner of PCM Trials and has more than 30 years of experience in managing and staffing global clinical trials with GCP-trained mobile research nurses for DCTs. The acquisition, which is effective immediately, expands PCM Trials' already extensive global footprint.

Company Information

Company

PCM Trials

Location

Denver, Colorado, United States

About

PCM Trials is leading the way in mobile research and decentralized clinical trials. Since 2008, PCM Trials has led the way in mobile research. Our Certified Mobile Research Nurses (CMRNs) are driving the shift to patient-centric, decentralized clinical trials, giving individuals the flexibility to engage in research studies in the ways that work best for them and expanding opportunities for participation. PROVEN RESULTS Faster Enrollment | Higher Retention | Improved Adherence | Greater Diversity | Uncompromised Data Quality PCM Trials has worked on 270+ protocols for 130+ sponsors and done 29,000+ visits.

Related People

Sign in to view contact details

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed